Literature DB >> 1317370

Comparative in-vitro activity of four peptide antibiotics against penicillin-resistant Streptococcus pneumoniae isolated from cerebrospinal fluid (CSF).

J L Rodríguez-Tudela1, F López de Felipe, J V Martínez-Suárez, A Fenoll.   

Abstract

The in-vitro activity of four peptide antibiotics against 43 penicillin-resistant Streptococcus pneumoniae isolated from cerebrospinal fluid (CSF) was evaluated. The activity of SKF104662 was slightly greater to that of vancomycin, teicoplanin and daptomycin (MICs for 90% of the isolates tested 0.06, 0.25, 0.12 and 0.25 mg/L, respectively) and superior to the other 15 drugs tested. The serotype of these penicillin-resistant strains was also determined. The strains that belonged to the predominant serotype 9 were resistant only to penicillin. All six erythromycin- and clindamycin-resistant strains belonged to serotype 6 and three of them were also resistant to chloramphenicol and tetracycline (plus penicillin).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1317370     DOI: 10.1093/jac/29.3.299

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  Killing kinetics of vancomycin and rifampin tested alone and in combination against penicillin-resistant Streptococcus pneumoniae.

Authors:  V Barakett; D Lesage; F Delisle; P Vergez; J C Petit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-01       Impact factor: 3.267

2.  Activity of teicoplanin and vancomycin against penicillin-resistant pneumococci.

Authors:  K P Klugman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

3.  Comparative activity of teicoplanin and vancomycin against 400 penicillin susceptible and resistant Streptococcus pneumoniae. The French Study Group.

Authors:  F W Goldstein; P Geslin; J F Acar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

4.  Activity of daptomycin against recent North American isolates of Streptococcus pneumoniae.

Authors:  M I Restrepo; J A Velez; M L McElmeel; C G Whitney; J H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.